I ran this through Google translate, you're welcome:
"demonstrated a sub-optimal safety profile" = every mouse injected grew tentacles from their spleens and started speaking Russian.
"Following a review of over 200 available compounds" = holy crap what do we do now, quick look under the couch someone
"a closely related analogue" = we have this sludge left in the test tube after making all that NYR-BI02....
"a superior safety profile" = tastes a bit like chicken actually
"commencing the preclinical, TBI efficacy and stroke model studies in the second half of this year" = And we are on track to be in the clinic sometime in Q3 2054.
NYR Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)